key: cord-0979565-8dunetdl authors: Bartha, Irene; Bernaola, Marta; Escudero, Carmelo; Rodríguez del Río, Pablo; Bazire, Raphaëlle; Ibáñez Sandín, Maria Dolores title: COVID‐19 and childhood asthma: Analysis of a pediatric referral hospital date: 2022-03-03 journal: Pediatr Allergy Immunol DOI: 10.1111/pai.13757 sha: 9f6a9cc0f594e14e0a6b424060437dc401af7800 doc_id: 979565 cord_uid: 8dunetdl nan severity of COVID-19 was established according to Qiu's classification. 4 The criteria used to classify as allergic or asthmatic patients included a specialized physician's diagnosis. A modified questionnaire on allergy and asthma based on a survey from the Asthma Committee of the Spanish Society of Allergy and Clinical Immunology was used. Qualitative variables are expressed as numbers and percentages, and the Fisher and chi-squared tests were used for comparison. Quantitative variables are expressed as mean and standard deviation (SD) or median and interquartile range (IQR) according to their distribution. Normality of age distribution was confirmed using the Shapiro-Wilk test. The Student T, ANOVA, and least significant difference (LSD) tests were used as post hoc tests to compare normally distributed variables. The Wilcoxon, Mann-Whitney U, and Kruskal-Wallis tests were used to compare nonparametric variables. Statistical significance was set at 95% (p < .05). Ninety-two children were identified as SARS-CoV-2-RT-PCR positive, two declined to participate. Asymptomatic patients were excluded. Fifty patients were diagnosed with symptomatic COVID-19 disease (52% male; mean age: 7 ± 7 years, IQR: 6 months-12 years) and finally enrolled (Figure 1 ). Regarding the severity, 37(74%) had mild-moderate COVID. The remainder developed a severe disease. Demographics and clinical features of asthmatic and nonasthmatic children with symptomatic COVID-19 were collected ( Table 1) . Eight of 50 symptomatic children had asthma with or without RC ( Figure 1 and Table 2 Table 1 ). Regarding evolution, three (37.5%) asthmatic patients remained with exercise-induced asthma; the remainder did not present any immediate sequelae at the time of writing this paper. None of the patients had issues to get access to medication or medical care during the pandemic. At the current stage of knowledge, children develop less severe symptoms of COVID-19, although the concern about the importance of underlying respiratory diseases, such as asthma, is still widely spread. 2,5,6 Furthermore, it has been studied whether severe asthma should be classified as a risk factor. 5, [7] [8] [9] In our study, we found that 16% of the patients were asthmatic. These patients had more respiratory symptoms due to COVID-19 disease. Comparing them with nonasthmatic patients, we could not find any other statistical difference regarding other variables, but this may be due to a reduce statistical power. However, the asthmatic group developed more eosinopenia, which was correlated with severity of the disease and also showed that recovery was lower compared to that of the nonasthmatic group. The prevalence of allergy and asthma in this cohort was 26% higher than that in other series published to date. 2,6,7,10 The age of our population, similar to the studies previously mentioned, might play a part to this issue as normally younger patients have allergic asthma and other allergic comorbidities. Our data showed that 76% of the total patients had mildmoderate COVID-19 disease. Similar findings have been published by the studies conducted in children. 2, 6, [8] [9] [10] [11] To our knowledge, this is the first study reporting comparisons between asthmatic and nonasthmatic pediatric patients with alterations in the chest x-ray. Literature is scarce on this topic as the major study performed in children used CT scan. 6 An Italian group showed 10% of patients with pneumonia, but neither this study nor others specify if these patients were asthmatic. 2, 6 Similar limitations are observed in the analysis of blood eosinophils. Eosinopenia is known to be a severity predictor in COVID-19 disease. 12, 13 In our cohort, asthmatic patients developed more eosinopenia and their recovery was lower compared to that of the nonasthmatic group. To date, no other studies have published similar data, and no relationship has access between COVID-19 disease, asthma, and eosinopenia. However, our results are conditioned on the number of participants enrolled, not all were followed before in our center, nor had a recent blood test done, so we could not compare whether this condition was previously ongoing, and it should be taken into account that moderate-severe forms of COVID-19 are more prone to have a blood test done. Recovery was full in all patients, as other studies have published. 2,6,10,11 Although, 37.5% of our asthmatic patients remained with exercise exacerbated asthma after COVID-19 disease. Pulmonary function tests were not performed afterwards, leading to limited information on the baseline pulmonary capacity in our population. Furthermore, despite being standardized tools, these could not be performed due to the risk of generating aerosols. Our study has limitations due to its retrospective nature and the age of the participants enrolled, which at the time this study was conducted, little was known about COVID-19 in this age group. In summary, to our knowledge, this is the first report describing asthma and other allergic comorbidities in children with confirmed COVID-19 disease. In our study, asthma has a low prevalence among COVID-19 pediatric patients with some differences related to their clinical manifestations of their disease and laboratory findings. Nevertheless, more studies are needed to assess the influence of asthma and allergy in COVID-19 disease due to the low number of patients included in all series. allergy, asthma, children, COVID-19, pediatric population None. Informe sobre la situación de COVID-19 en España. Red Nacional de Vigilancia Epidemiológica Allergy and asthma in children and adolescents during the COVID outbreak: what we know and how we could prevent allergy and asthma flares Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor, ACE2 Olfactory and gustatory dysfunction as an early identifier of COVID-19 in adults and children: an international multicenter study Managing childhood allergies and immunodeficiencies during respiratory virus epidemics -The 2020 COVID-19 pandemic: a statement from the EAACI-section on pediatrics Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status Presenting prevalence, characteristics and outcome of asthmatic patients with T2 diseases in hospitalized subjects with COVID-19 in Madrid, Spain Asthma and COVID-19 in children: a systematic review and call for data Pediatric asthma and COVID-19: the known, the unknown, and the controversial Impact of COVID-19 on pediatric asthma: practice adjustments and disease burden Impact of the COVID-19 pandemic in children with allergic asthma Eosinophil responses during COVID-19 infections and coronavirus vaccination Eosinophils and chronic respiratory diseases in hospitalized COVID-19 patients